Clinical Trial for Hypofractionated (4 Fraction) Heavy Ion Therapy for Ocular / Choroidal Melanoma
Phase 1
- Conditions
- Ocular / Choroidal Melanoma
- Registration Number
- JPRN-UMIN000022302
- Lead Sponsor
- ational Institutes for Quantum and Radiological Science and Technology National Institute of Radiological Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Existence of past treatment against the lesion. 2. Existence of extra-ocular lesion including metastasis. 3. Life expectancy shorter than 6 months 4. Active infection within the irradiation field 5. Existence of other active malignancies. 6. Existence of severe complications 7. Evaluated not able to complete this study because of serious medical or psychological problems
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ormal tissue acute toxicity. (to be evaluated at end of treatment, 3 months and 6 months post-treatment.
- Secondary Outcome Measures
Name Time Method Initial response Local control rate Normal tissue late toxicity Overall survival rate Eye retention rate